Udhayanidhi Stalin launches coffee table book on Chennai Corporation
A 262-page book, Chennai Corporation — The Jewel in the Crown, which was curated by The Hindu Group for the Greater Chennai Corporation (GCC), was launched by Deputy Chief Minister Udhayanidhi Stalin at the Ripon Buildings on Wednesday.
The book provides an overview of the historical significance of the world's second oldest corporation, moving through the years to chronicle not just its past but also the present and its future. Punctuated by archival images exclusively in The Hindu's possession, the book not only pays homage to the civic body but also invokes the emotion of the grand old city of Madras.
In the book's foreword, Chief Minister M.K Stalin wrote: 'It is with great pleasure that I welcome this venture between the Greater Chennai Corporation and The Hindu to publish a coffee-table book on the Corporation.'
Minister for Municipal Administration and Water Supply K.N. Nehru wrote, 'This coffee-table book produced by The Hindu, is a remarkable tribute to the Corporation's enduring legacy through rare archival photographs, insightful interviews, and perspectives.'
Chennai Mayor R. Priya said: 'In the past three years, the GCC has focused on building storm-water drains, 11 bridges, and improving school infrastructure in added areas.'
L.V. Navaneeth, Chief Executive Officer, The Hindu Group, Sridhar Aranala, vice-president (sales and distribution), Srinivasan R., head (magazines and special publications), and Babu Vijay R.A., senior general manager (circulation), were present.
The book will be available exclusively through the GCC.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
8 hours ago
- United News of India
CREDAI Hyderabad elects New Managing Committee members for 2025-27
Hyderabad, June 20 (UNI) The Confederation of Real Estate Developers Association of India (CREDAI) Hyderabad on Friday announced the appointment of a new managing committee for the period 2025 to 2027, which will be responsible for spearheading and strengthening the CREDAI initiatives in Hyderabad and supporting the development of the sector in the region. N. Jaideep Reddy is the President, B. Jagannath Rao is the President-Elect, and Manoj Kumar Agarwal, Kurra Srinath, K. Anil Reddy and Y. Ravi Prasad are Vice Presidents. Kranti Kiran Reddy K is the General Secretary in the new team. Nitish Reddy Gudoor is the Treasurer and Sanjay Kumar Bansal and Sriram Musunuru are Joint Secretaries. The Executive Committee members are -- Addula Gopal Reddy, Alugubelli Venkat Reddy, B Jaipal Reddy, B Vinod Reddy, C Amarendher Reddy, Kavya Kavuri (the first woman elected as an EC member), N Venugopal, and Susheel Kumar Jain, who will all work together for the betterment of the Hyderabad real estate sector. The new team has adopted the theme of 'Embracing Growth and Innovation' as the core guiding principle for the activities to be undertaken during their tenure. They will focus on forward-looking themes encouraging adoption of new technology and encouraging innovation for smarter construction, adopt sustainable urban development, focus on curated skilling programmes for construction, project management and marketing while expanding real estate activities in the city. The team will focus on enhanced collaboration with the Telangana government, active participation in policy advocacy and promoting 'Brand Hyderabad' to strengthen the city's reputation as India's most dynamic real estate destination. Outlining the agenda of the new Managing Committee, newly elected President Jaideep Reddy, said, "As the city expands in all directions, driven by global capability centers (GCC), infrastructure upgrades, and a maturing real estate landscape, we are witnessing a clear shift toward premium living and sustainable development. CREDAI Hyderabad will continue to be a catalyst in this journey—by supporting homebuyers with trust, transparency, and timely delivery. We will empower the developers through proactive engagement, policy support, and skilling of manpower with future-ready solutions. With 'Embracing Growth and Innovation' as our guiding theme, we are committed to encourage adoption of new systems for construction and shaping a resilient, high-growth future of the Real Estate Sector in the city that leaves no one behind." 'The reports from all consultants and research agencies confirm Hyderabad's fundamentals are strong, marked by rising office space absorption and growing demand for larger, high-quality homes. CREDAI Hyderabad will continue to champion RERA compliance, advocate for ease of doing business, and collaborate with the government to build not just homes—but legacies," he added. Newly-elected General Secretary Kranti Kiran Reddy K, said, "The Hyderabad residential market is demonstrating renewed strength, with over Rs 4,000 crore in registrations in May 2025 — driven by a noticeable 37% rise in high-end home sales. This reflects growing buyer confidence and a shift toward premium and lifestyle-focused living. At CREDAI Hyderabad, we see this as an opportunity for growth and support this upward trend through continued policy advocacy, transparent processes, and enhanced adoption of new mechanisms and digital platforms—ensuring sustainable growth and investor trust across all segments." UNI KNR RN
Time of India
10 hours ago
- Time of India
Genpact to employees: Follow 10-hour workday 'mandate' or face performance review
Genpact has implemented a new policy requiring a 10-hour workday for its employees, which will be effective mid-June, a report claims. Employees who fail to comply with this mandate may reportedly face performance reviews. Tired of too many ads? go ad free now However, the policy does not include a corresponding increase in base salary, the report adds. According to a report by The Hindu, the tech and services company will track employee productivity through an internal tool that will monitor their daily active hours. Employees meeting the required hours can reportedly earn up to 500 points monthly, which will be equivalent to Rs 3,000 in incentives. The report also adds that an additional 5% bonus, which is nearly Rs 150, will be paid to employees for any extra time logged beyond the 10-hour mandate. How Genpact employees have reacted to the 10-hour workday mandate Genpact's recent policy rollout has led to growing unrest among employees, particularly in the Hyderabad office, where the atmosphere has been described as 'tense' and morale appears low, the report adds. As per the report, the approach to implementing the policy has also added to the concerns, as it was communicated informally by managers and team leads rather than through official HR channels. Several employees have raised issues about the lack of clarity, with one senior recruitment staff member telling The Hindu: 'There's nothing on paper. It's all word of mouth. If anyone challenges it, they're accused of being difficult and risk termination.' A current employee also took to social media to share his concerns about the company's practices. A LinkedIn user, who identified as a Genpact employee, pointed out that requiring a 10-hour login can affect productivity. In a LinkedIn post, Abhishek Sharma who works as an assistant manager at Genpact wrote: '#For10HrLogin – Is this the new standard or a step backward? As professionals striving for excellence, we're no strangers to going the extra mile. Tired of too many ads? go ad free now But mandating a 10-hour login raises some important questions about work-life balance, productivity, and mental health. In today's world where efficiency and output matter more than screen time, shouldn't we focus on results, not hours? Extended login hours can lead to burnout, reduced creativity, and disengagement. I urge leadership to reconsider – is this sustainable, and is it truly what drives growth? Open to hearing others' views. Let's talk about healthier, smarter ways to work."
Hans India
16 hours ago
- Hans India
ZeroHarm Eyes Rs 150 Crore Milestone by FY 2025 -'26, Accelerates Global Expansion into GCC
ZeroHarm Sciences, India's pioneering clean-label nutraceutical company, is set to accelerate its global footprint with a focused expansion into the GCC markets, including the UAE and the broader Middle East. Following a remarkable 10× revenue growth over the past two years and operating at a healthy ~20% EBITDA margin, the company closed the last fiscal year with 71 crore in gross revenue with an exit ARR of 90 crores. In the current fiscal, ZeroHarm is aiming for ₹150 crore in gross revenue, driven by strong domestic and global momentum and increasing traction in the United States, which now contributes nearly 30% of its overall revenue. At the heart of ZeroHarm's global success is its patented ZeroHarm BioEnhance platform, a pharma-grade nanotechnology that encapsulates plant-based actives at the nanoscale, dramatically enhancing their bioavailability by up to 5×, ensuring faster onset, precise dosing, and residue-free delivery. This breakthrough, backed by granted patents and deep R&D, makes ZeroHarm the first Indian company to bring pharmaceutical nanotech into nutraceuticals at scale. ZeroHarm's US FDA, CE, and ISO-certified formulations are backed by government-led clinical trials, with documented claims for 15 products, setting it apart in a market rife with unverified health claims. Today, the company offers over 70 targeted, condition-specific products spanning diabetes, arthritis, PCOS, liver and kidney health, immunity, and oncology support, with over million units sold across India to date. Backed by a fully owned, nanotech-enabled manufacturing facility, ZeroHarm can produce up to ₹250 crore worth of finished goods annually, making it one of the few Indian nutraceutical brands with true end-to-end production capabilities. To support its international expansion, ZeroHarm has acquired a dedicated manufacturing and R&D facility in the United States, enhancing local supply chain efficiency, fast-tracking formulation innovation, and enabling closer clinical and regulatory collaborations in key global markets. The U.S. infrastructure also gives ZeroHarm a significant strategic edge in developed markets, where stringent compliance standards often limit entry for Indian nutraceutical brands reliant on contract manufacturing. 'The global nutraceutical market is shifting, consumers are demanding not just clean labels, but clinical credibility. At ZeroHarm, we've combined deep R&D with pharma-grade nanotechnology to raise the bar for efficacy, safety, and transparency in preventive wellness. Our entry into the GCC is a natural extension of the trust we've built in India and the U.S., and a significant step toward making evidence-backed, plant-based therapeutics accessible to global consumers,' said Sachin Darbarwar, Founder & CEO, ZeroHarm Sciences. With distribution agreements and regulatory filings already underway, the company will also launch in the UK aside from the GCC markets by Q3 2025, introducing its clinically tested product lines via pharmacies, e-commerce platforms, and integrative practitioner networks.
